Fralick Celeste Rachelle 4
4 · Aspira Women's Health Inc. · Filed Apr 1, 2025
Insider Transaction Report
Form 4
Fralick Celeste Rachelle
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-03-31−5,000→ 5,000 total→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2025-03-31+5,000→ 55,665 total
Footnotes (3)
- [F1]Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on March 31, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.
- [F2]Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.
- [F3]On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4.